Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Starpharma Holdings Ltd (SPHRY)

Starpharma Holdings Ltd (SPHRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Starpharma Holdings Ltd 4-6 Southampton Crescent Abbotsford C3 3067 AUS

www.starpharma.com Employees: 40 P: 61-3-8532-2700

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.

Key Statistics

Overview:

Market Capitalization, $K 98,282
Enterprise Value, $K 88,592
Shares Outstanding, K 41,822
Annual Sales, $ 3,790 K
Annual Net Income, $ -6,470 K
EBIT, $ 0 K
EBITDA, $ -5,780 K
60-Month Beta 0.92
% of Institutional Shareholders 0.00%
Float, K 41,822
% Float 100.00%
Short Volume Ratio 0.03

Growth:

1-Year Return 214.38%
3-Year Return -54.81%
5-Year Return -68.83%
5-Year Revenue Growth -20.71%
5-Year Earnings Growth 51.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm 0.00
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SPHRY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -170.71%
Debt/Equity 0.02
Price/Sales 34.18
Price/Cash Flow N/A
Price/Book 8.84
Book Value/Share 0.29
Interest Coverage -0.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar